Condition: Endometrial Neoplasms · Atypical Endometrial Hyperplasia · Progesterone Resistance · Sponsor: Xiaojun Chen
To investigate the efficacy of GnRHa plus letrozole in obese progestin-insensitive EEC patients.
This description comes directly from the study's public registry record.
Xiaojun Chen, PhD · 8602133189900 · cxjlhjj@163.com
Pengfei Wu · 8602133189900 · leofinger@163.com
Always discuss trial participation with your own doctor first.
| Tenth People's Hospital of Tongji University | Shanghai, Shanghai Municipality, China | Recruiting |
| Obstetrics and Gynecology Hospital, Fudan University | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06379113